BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10360373)

  • 1. Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia.
    Chen Y; Pan M; Chen L; Peng M; Liu Z; Fang Y; Du Y; Yang Y; Xu P
    Ann Hematol; 2024 Apr; 103(4):1181-1185. PubMed ID: 38294534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.
    Korsos V; Miller WH
    J Mol Endocrinol; 2022 Nov; 69(4):T69-T83. PubMed ID: 36112505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies.
    de Thé H; Le Bras M; Lallemand-Breitenbach V
    J Cell Biol; 2012 Jul; 198(1):11-21. PubMed ID: 22778276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.
    Xu J; Li H; Wang Z; Wang M; Li Q; Hang X; Xu J; Ji J; Chen C; Liu Y; Niu T
    Mol Carcinog; 2024 Apr; 63(4):553-557. PubMed ID: 38131515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-biological features of 30 patients with acute promyelocytic leukemia and response to combination induction chemotherapy with all-trans retinoic acid and anthracycline.
    Lim LC; Vellupillai M; Ghafar AA
    Med Oncol; 2000 Nov; 17(4):301-6. PubMed ID: 11114709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case.
    Tao T; Cen J; Xu C; Chen Y; Cao Y; Gong Y; Zhu M; Chen S; Zhang Q; Yao L
    Mol Carcinog; 2024 Apr; 63(4):558-562. PubMed ID: 38153216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia.
    Jiang M; Wang X; Yu M; Jiang S; Hong M; Zhou Y; Li F; Liu H; Zhang Z
    Am J Hematol; 2024 May; 99(5):1005-1007. PubMed ID: 38410879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the
    Castelijn DAR; Sijm G; Venniker-Punt B; Poddighe PJ; Wondergem MJ
    Case Rep Oncol; 2023; 16(1):1443-1450. PubMed ID: 38028572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence.
    Pantic M; Novak A; Marisavljevic D; Djordjevic V; Elezovic I; Vidovic A; Colovic M
    Med Oncol; 2000 Nov; 17(4):307-13. PubMed ID: 11114710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia.
    Zhang Q; Li H; Chen X; Gu F; Zhang L; Zhang L; Chen T; Chen Q; Meng W; Wu Y; Chang H; Liu T; Chen C; Ma H; Liu Y
    Blood; 2023 Oct; 142(17):1494-1499. PubMed ID: 37624915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML/RARa leukemia induced murine model for immunotherapy evaluation.
    Shiraishi RN; Bombeiro AL; Castro TCL; Della Via FI; Santos I; Rego EM; Saad STO; Torello CO
    Transpl Immunol; 2023 Dec; 81():101919. PubMed ID: 37598913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias.
    Poplineau M; Platet N; Mazuel A; Hérault L; N'Guyen L; Koide S; Nakajima-Takagi Y; Kuribayashi W; Carbuccia N; Haboub L; Vernerey J; Oshima M; Birnbaum D; Iwama A; Duprez E
    Blood; 2022 Dec; 140(22):2358-2370. PubMed ID: 35984905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classic and Variants APLs, as Viewed from a Therapy Response.
    Geoffroy MC; de Thé H
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia.
    Mozziconacci MJ; Liberatore C; Grignani F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Leukemia; 1999 Jun; 13(6):862-8. PubMed ID: 10360373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
    Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
    Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
    Redner RL; Rush EA; Faas S; Rudert WA; Corey SJ
    Blood; 1996 Feb; 87(3):882-6. PubMed ID: 8562957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.